NCT00003702View on ClinicalTrials.gov

Methotrexate Compared With Dactinomycin in Treating Patients With Gestational Trophoblastic Neoplasia

PHASE3CompletedINTERVENTIONAL
Enrollment

240

Participants

Timeline

Start Date

June 30, 1999

Primary Completion Date

July 31, 2010

Conditions
Good Prognosis Metastatic Gestational Trophoblastic TumorHydatidiform MoleNon-Metastatic Gestational Trophoblastic TumorUterine Corpus Choriocarcinoma
Interventions
BIOLOGICAL

Dactinomycin

Given IV

DRUG

Methotrexate

Given intramuscularly

Trial Locations (1)

19103

Gynecologic Oncology Group, Philadelphia

All Listed Sponsors
collaborator

Eastern Cooperative Oncology Group

NETWORK

collaborator

National Cancer Institute (NCI)

NIH

lead

Gynecologic Oncology Group

NETWORK

NCT00003702 - Methotrexate Compared With Dactinomycin in Treating Patients With Gestational Trophoblastic Neoplasia | Biotech Hunter | Biotech Hunter